Early effects of transplatin on oncogene activation in vivo.

Németh, A; Nádasi, E; Beró, A; Olasz, L; Ember, A; Kvarda, A; Bujdosó, L; Arany, I; Csejtei, A; Faluhelyi, Zs; Ember, I

Németh, A; Nádasi, E; Beró, A; Olasz, L; Ember, A; Kvarda, A; Bujdosó, L; Arany, I; Csejtei, A; Faluhelyi, Zs; Ember, I.

Affiliation

Németh A; Department of Public Health, Faculty of Medicine, University of Pécs, Hungary. arpadnemeth@freemail.hu

Anticancer Res ; 24(6): 3997-4001, 2004.

Article in En | MEDLINE | ID: mdl-15736445

Subject(s)

Cisplatin/pharmacology; Genes, myc/drug effects; Genes, p53/drug effects; Genes, ras/drug effects; Animals; Female; Gene Expression Regulation/drug effects; Genes, myc/genetics; Genes, p53/genetics; Genes, ras/genetics; Kidney/drug effects; Kidney/physiology; Liver/drug effects; Liver/physiology; Lung/drug effects; Lung/physiology; Mice; Mice, Inbred CBA; Spleen/drug effects; Spleen/physiology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Genes, myc / Genes, p53 / Genes, ras / Cisplatin Limits: Animals Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Genes, myc / Genes, p53 / Genes, ras / Cisplatin Limits: Animals Language: En Year: 2004 Type: Article